Hershey vs. Mondelez: Which Stock Wins Chocolate Season?

Hershey (HSY) has significantly outperformed Mondelez (MDLZ) this year, despite both facing headwinds from soaring cocoa prices and GLP-1 drug impacts on demand. Hershey's success stems from its ability to implement a 26% price increase and strategic diversification into non-chocolate categories and salty snacks, which has shielded margins and led to a 23% earnings surprise. Conversely, Mondelez has primarily relied on cost controls, resulting in a steeper 15% EPS decline and a smaller 7% earnings beat, with its ability to pass on price hikes remaining a critical near-term challenge and determinant of its potential upside, despite both stocks trading at premiums.

Analysis

Despite sector-wide headwinds from soaring cocoa prices and the demand-dampening effects of GLP-1 drugs, Hershey (HSY) has demonstrated superior operational execution compared to Mondelez (MDLZ), leading to its stock outperforming its rival by nearly 2:1 year-to-date. Hershey's strategy of implementing a significant price increase of approximately 26% on key brands, coupled with successful diversification into non-chocolate categories like gummies and salty snacks, has effectively shielded its margins. This is evidenced by a substantial 23% earnings surprise and a modest 3% year-over-year EPS decline. In contrast, Mondelez has primarily relied on cost-cutting measures, resulting in a steeper 15% EPS drop and a smaller 7% earnings beat. While analysts' consensus suggests potential upside for MDLZ, its performance is contingent on its yet-unproven ability to pass on higher costs to consumers this quarter. The divergence in strategy and results has attracted bullish analyst sentiment for Hershey, including a significant upgrade from Goldman Sachs, which raised its rating from Sell to Buy with a price target of $220, suggesting a 15% upside.

Key Decisions for Investors

• Investors seeking relative safety within the challenged confectionary sector may favor Hershey (HSY) for its demonstrated pricing power and successful diversification strategy, which provide a clearer path to navigating current headwinds.
• Mondelez (MDLZ) presents a higher-risk, event-driven scenario; positions should be considered with caution, pending confirmation in the next earnings report that the company can successfully implement price increases to improve its margin and earnings trajectory.
• Monitor cocoa commodity futures and data on consumer spending habits related to GLP-1 drugs, as these macro factors remain primary risks for both companies and could override individual company performance.
• Given the recent bullish upgrades and strong execution, consider that Hershey may be breaking away as the preferred name in the space, warranting a potential pair trade of long HSY and short MDLZ for investors with a higher risk tolerance.